Risk factors and secondary care utilisation in a primary care population with non-tuberculous mycobacterial disease in the UK

被引:0
|
作者
Eleanor L. Axson
Navdeep Bual
Chloe I. Bloom
Jennifer K. Quint
机构
[1] Imperial College London,Respiratory Epidemiology, Occupational Medicine and Public Health, National Heart and Lung Institute
关键词
Epidemiology; Risk factors; NTM; COPD; Bronchiectasis;
D O I
暂无
中图分类号
学科分类号
摘要
Prior research has identified risk factors associated with developing non-tuberculous mycobacterial disease (NTMD); we identified risk factors and secondary care utilisation of NTMD patients in the UK. This was a matched case-control study using electronic healthcare records from Clinical Practice Research Datalink from 2006 to 2016. NTMD was defined using prescription data and Read codes, based on international guidelines. Risk factors for NTMD were investigated using conditional logistic regression within a representative general population. All-cause secondary care utilisation (combined inpatient, outpatient, emergency visits) was investigated for participants with linked Hospital Episode Statistics (HES), using incidence rate ratio (IRR) from 2007 to 2015. We identified 1225 individuals with NTMD. A subset of individuals (426 patients) were eligible for linkage with HES. In the adjusted model, risk factors most strongly associated with an increased likelihood of NTMD included previous tuberculosis (OR 69.0; 47.7–99.8); bronchiectasis (OR 23.3; 12.4–43.9); lung cancer (OR 14.9; 3.98–55.7); oral corticosteroids (OCS; OR 7.28; 4.94–10.7); immunosuppressive (excluding corticosteroids) medication (OR 3.05; 1.15–8.10); being underweight (odds ratio (OR) 2.92; 95% CI 1.95, 4.36); and rheumatoid arthritis (OR 2.12; 1.05–4.27). NTMD patients had significantly higher rates of all-cause secondary care utilisation than non-NTMD patients (IRR 5.80; 5.14–6.46). Using a representative adult population, we identified prior TB, bronchiectasis, lung cancer, immunosuppressive medication, and OCS as the risk factors associated with the highest odds of developing NTMD in the UK. Patients with NTMD experienced nearly six times more all-cause secondary care events following their NTMD diagnosis than patients without NTMD.
引用
收藏
页码:117 / 124
页数:7
相关论文
共 50 条
  • [41] The key factors contributing to the risk, diagnosis and treatment of non-tuberculous mycobacterial opportunistic infections
    Grzegorzewicz, Anna
    Pasciak, Mariola
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2021, 75 (01): : 696 - 710
  • [42] THE ECONOMIC IMPACT AND VARIABILITY OF MANAGING NON-TUBERCULOUS MYCOBACTERIAL LUNG DISEASE IN THE UK HEALTHCARE SETTING
    Mumford, A.
    Mumford, J.
    Dixon, C.
    VALUE IN HEALTH, 2018, 21 : S409 - S410
  • [43] Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK
    Lipman, Marc
    Cleverley, Joanne
    Fardon, Tom
    Musaddaq, Besma
    Peckham, Daniel
    van der Laan, Roald
    Whitaker, Paul
    White, Jacqui
    BMJ OPEN RESPIRATORY RESEARCH, 2020, 7 (01)
  • [44] Clinical characteristics and prognostic factors of non-tuberculous mycobacterial disease in patients with rheumatoid arthritis
    Kim, Hyemin
    Lee, Soyoung
    Kim, Ji-Won
    Jung, Ju -Yang
    Suh, Chang -Hee
    Kim, Hyoun-Ah
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2024, 39 (01): : 172 - 183
  • [45] Factors Associated With Lung Function Decline In Patients With Non-Tuberculous Mycobacterial Pulmonary Disease
    Chang, K.
    Lee, M. -R.
    Yang, C. -Y.
    Keng, L. -T.
    Yen, D. H.
    Wang, J. -Y.
    Wu, H. -D.
    Lee, L. -N.
    Yu, C. -J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [46] Factors Associated with Lung Function Decline in Patients with Non-Tuberculous Mycobacterial Pulmonary Disease
    Lee, Meng-Rui
    Yang, Ching-Yao
    Chang, Kai-Ping
    Keng, Li-Ta
    Yen, David Hung-Tsang
    Wang, Jann-Yuan
    Wu, Huey-Dong
    Lee, Li-Na
    Yu, Chong-Jen
    PLOS ONE, 2013, 8 (03):
  • [47] Non-tuberculous mycobacterial infections in patients with end-stage renal disease: prevalence, risk factors, and mortality
    Toth, Eszter
    Waller, Jennifer L.
    Bollag, Wendy B.
    Siddiqui, Budder
    Mohammed, Azeem
    Kheda, Mufaddal
    Padala, Sandeep
    Young, Lufei
    Baer, Stephanie L.
    Tran, Sarah
    JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (07) : 707 - 715
  • [48] Non-tuberculous mycobacterial disease associated with Mycobacterium montefiorense in salamanders
    Komine, Takeshi
    Ihara, Hyogo
    Inohana, Mari
    Kwok, Jennifer Caroline
    Shimizu, Akane
    Terasawa, Tsumugi
    Miyazaki, Ayaka
    Srivorakul, Saralee
    Iwao, Hajime
    Harada, Sachiko
    Yoshida, Mitsunori
    Hoshino, Yoshihiko
    Kurata, Osamu
    Fukano, Hanako
    Wada, Shinpei
    FRONTIERS IN VETERINARY SCIENCE, 2023, 10
  • [49] Prognostic serum biomarkers in non-tuberculous mycobacterial pulmonary disease
    Park, Hyun-Jun
    Kim, Joong-Yub
    Yim, Jae-Joon
    Kwak, Nakwon
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (10) : 1005 - 1007
  • [50] Personalised Medicine for Tuberculosis and Non-Tuberculous Mycobacterial Pulmonary Disease
    Kumar, Kartik
    Kon, Onn Min
    MICROORGANISMS, 2021, 9 (11)